- New
Retatrutide 30MG
£120.00
Tax included
Delivered within 3-4 Days
Security policy
(edit with the Customer Reassurance module)
Delivery policy
(edit with the Customer Reassurance module)
Return policy
(edit with the Customer Reassurance module)
3ml of bacteriostatic water included
https://janoshik.com/tests/122619-Retatrutide_30mg_ILSS1TIFWUEM
https://janoshik.com/tests/86467-Retatrutide_30mg_45824F9UEVP3
Retatrutide is an investigational triple receptor agonist peptide targeting GLP-1, GIP, and glucagon receptors.
It is currently being studied for its potential impact on metabolic regulation and body weight management in research settings.
Key Research Characteristics
- Triple agonist activity: GLP-1 / GIP / Glucagon receptors
- Designed to influence both energy intake and energy expenditure
- Long-acting peptide under clinical development
Mechanism Overview
Retatrutide combines incretin receptor activation (GLP-1 and GIP) with glucagon receptor stimulation.
This multimodal approach is being investigated for its potential to:
- Support glucose-dependent insulin signaling
- Modulate appetite pathways
- Increase metabolic rate and lipolysis
- Influence cardiometabolic biomarkers
Research Applications
- Obesity and metabolic disorder research
- Glucose metabolism studies
- Energy balance and fat metabolism investigations
- Hepatic fat and cardiometabolic marker evaluation
For research use only. Not for human consumption.
30 Items
Comments (0)
No customer reviews for the moment.